Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$524M |
| 2 |
Meta Platforms (Facebook)
META
|
+$458M |
| 3 |
Otis Worldwide
OTIS
|
+$345M |
| 4 |
T-Mobile US
TMUS
|
+$307M |
| 5 |
AbbVie
ABBV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$435M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
Accenture
ACN
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.72% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Denali Therapeutics
DNLI
$3.92B
| $26.1M | 0.01% |
1,080,950
+98,431
| +10% | +$2.31M |
|
1302
Xencor
XNCR
$1.49B
| $26.1M | 0.01% |
805,887
+74,322
| +10% | +$2.28M |
|
1303
Agnico Eagle Mines
AEM
$85B
| $26M | 0.01% |
407,869
+30,265
| +8% | +$1.79M |
|
1304
AeroVironment
AVAV
$8.66B
| $26M | 0.01% |
326,510
+8,674
| +3% | +$559K |
|
|
BMCH
1305
DELISTED
BMC Stock Holdings, Inc
BMCH
| $26M | 0.01% |
1,033,612
+18,319
| +2% | +$405K |
|
1306
Rambus
RMBS
$10.6B
| $26M | 0.01% |
1,707,593
+59,443
| +4% | +$837K |
|
1307
Adaptive Biotechnologies
ADPT
$3.75B
| $25.9M | 0.01% |
536,132
+68,896
| +15% | +$2.51M |
|
1308
NETSCOUT
NTCT
$2.92B
| $25.9M | 0.01% |
1,013,782
-7,138
| -0.7% | -$184K |
|
1309
Appian
APPN
$2.23B
| $25.8M | 0.01% |
504,355
+5,510
| +1% | +$269K |
|
|
SAGE
1310
DELISTED
Sage Therapeutics
SAGE
| $25.8M | 0.01% |
620,400
+25,158
| +4% | +$913K |
|
|
CIM
1311
Chimera Investment
CIM
$993M
| $25.8M | 0.01% |
894,514
+166,688
| +23% | +$4.28M |
|
1312
Fluor
FLR
$6.81B
| $25.7M | 0.01% |
2,131,201
+485,030
| +29% | +$5.09M |
|
1313
SPX Corp
SPXC
$10.7B
| $25.7M | 0.01% |
625,635
+15,325
| +3% | +$577K |
|
1314
Jack in the Box
JACK
$331M
| $25.7M | 0.01% |
346,783
-25,847
| -7% | -$1.59M |
|
|
ILPT
1315
Industrial Logistics Properties Trust
ILPT
$575M
| $25.7M | 0.01% |
1,249,864
+280,758
| +29% | +$5.15M |
|
1316
Albany International
AIN
$1.74B
| $25.6M | 0.01% |
436,648
+6,276
| +1% | +$339K |
|
1317
Corcept Therapeutics
CORT
$11.7B
| $25.6M | 0.01% |
1,523,954
+44,693
| +3% | +$628K |
|
1318
TripAdvisor
TRIP
$1.22B
| $25.6M | 0.01% |
1,347,989
-20,120
| -1% | -$384K |
|
1319
Federal Signal
FSS
$7.8B
| $25.6M | 0.01% |
861,654
+29,497
| +4% | +$835K |
|
|
VRE
1320
DELISTED
Veris Residential
VRE
| $25.6M | 0.01% |
1,673,929
+16,169
| +1% | +$251K |
|
|
STL
1321
DELISTED
Sterling Bancorp
STL
| $25.6M | 0.01% |
2,181,917
-242,689
| -10% | -$2.78M |
|
1322
Dana Inc
DAN
$2.94B
| $25.5M | 0.01% |
2,094,673
+61,528
| +3% | +$669K |
|
|
MNR
1323
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $25.5M | 0.01% |
1,760,332
+403,430
| +30% | +$5.24M |
|
|
ROIC
1324
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $25.5M | 0.01% |
2,251,242
+52,770
| +2% | +$511K |
|
1325
Essential Properties Realty Trust
EPRT
$6.62B
| $25.5M | 0.01% |
1,716,007
+392,023
| +30% | +$5.4M |
|
Similar funds
Geode Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Geode Capital Management held 4,219 positions worth $467B, up 22% from $384B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q2 2020 filing shows 118 new, 2,550 increased, 1,055 reduced and 119 closed positions. Its largest new stake was Otis Worldwide: 6,650,358 shares worth $377M. The largest sale was Allergan plc, an estimated $878M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2020 buy was Otis Worldwide: 6,650,358 shares worth $377M.
- Geode Capital Management added most to Amazon in Q2 2020, an estimated $524M increase.
- Geode Capital Management's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $435M.
- Geode Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $878M.
- Geode Capital Management's ten largest holdings make up 23% of its $467B portfolio in Q2 2020.
- Geode Capital Management opened 118 new positions and closed 119 in Q2 2020.
- Geode Capital Management's portfolio value rose 22% quarter-over-quarter to $467B.
Based on Geode Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.